Sebastián Elías Cobeña Guerrero

Sebastián Elías Cobeña Guerrero

Auto-generated profile, based on publicly available information

Sebastián Elías Cobeña Guerrero

UEES

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 December 2025 in IECCMEXICO
Verified
Journal Article
Closed access
MBMayra Isabel Moreno Bautista
Mayra Isabel Moreno Bautista
SGSebastián Elías Cobeña Guerrero
Sebastián Elías Cobeña Guerrero
MCManuel José Cedeño Castillo
Manuel José Cedeño Castillo
KGKevin Emmanuel Leony Gallegos
Kevin Emmanuel Leony Gallegos
OPOscar René González Páez
Oscar René González Páez
BHBraulio Hernández Hidalgo
Braulio Hernández Hidalgo
Systemic diseases frequently produce ophthalmologic manifestations that may function as early indicators of underlying metabolic, vascular, neurological, autoimmune, infectious, and inflammatory disorders. The present review aimed to analyze the principal ocular manifestations associated with systemic diseases and evaluate their diagnostic and clinical implications within ophthalmology, internal medicine, endocrinology, neurology, and related medical specialties. A narrative review methodology based on scientific literature analysis was employed using internationally recognized databases including PubMed, Scopus, ScienceDirect, SpringerLink, and Google Scholar. Recent peer-reviewed studies addressing ocular complications associated with systemic diseases were selected and analyzed. The reviewed evidence demonstrated that endocrine and vascular disorders, particularly diabetes mellitus and arterial hypertension, represent the principal causes of systemic disease-associated ocular pathology worldwide. Diabetic retinopathy, hypertensive retinopathy, retinal vascular disease, optic neuropathy, thyroid eye disease, and inflammatory ocular conditions emerged as the most frequently reported manifestations. Neurological diseases such as multiple sclerosis and intracranial hypertension were strongly associated with neuro-ophthalmologic abnormalities including optic neuritis and papilledema. Autoimmune disorders including systemic lupus erythematosus, Behçet’s disease, and Sjögren syndrome demonstrated substantial inflammatory ocular involvement.

27 December 2025 in IECCMEXICO
Verified
Journal Article
Open access
PDF file
ESEsteban Marrufo Sumano
Esteban Marrufo Sumano
SGSebastián Elías Cobeña Guerrero
Sebastián Elías Cobeña Guerrero
KPKevin Omar Cortez Pilco
Kevin Omar Cortez Pilco
WMWilliam Patricio Alvarez Morales
William Patricio Alvarez Morales
JRJosé Eduardo Vallejo Ramírez
José Eduardo Vallejo Ramírez
MGMaría Fernanda Portilla Galvan
María Fernanda Portilla Galvan
Perioperative systemic inflammation is a complex physiological response generated by surgical trauma and represents one of the principal determinants of postoperative outcomes in modern surgical practice. This review aimed to analyze the multisystem impact of perioperative inflammation, including its pathophysiological mechanisms, inflammatory biomarkers, organ dysfunction, and current perioperative management strategies. A structured narrative review was conducted using scientific literature obtained from international databases including PubMed, Scopus, ScienceDirect, and related peer-reviewed medical sources. The analyzed evidence demonstrated that perioperative inflammation involves coordinated activation of cytokines, neuroendocrine pathways, endothelial dysfunction, oxidative stress, and immune dysregulation. Elevated inflammatory markers such as interleukin-6, C-reactive protein, and neutrophil-to-lymphocyte ratio were consistently associated with postoperative complications including cardiovascular instability, pulmonary dysfunction, acute kidney injury, infectious complications, delayed gastrointestinal recovery, and prolonged hospitalization. Modern perioperative strategies such as Enhanced Recovery After Surgery protocols, minimally invasive surgery, multimodal analgesia, immunonutrition, and goal-directed physiological optimization demonstrated beneficial effects in reducing inflammatory burden and improving postoperative recovery. The findings emphasize that perioperative systemic inflammation should be understood as a multisystem process requiring multidisciplinary perioperative management. Continued research focused on personalized inflammatory profiling, biomarker-guided monitoring, and targeted immunomodulation may contribute to improved postoperative outcomes and more individualized surgical care in the future.